But wait, there’s more! Generative AI is like the superhero cape against unconscious biases. It throws each candidate into a mix of potential applications way beyond one expert’s turf. Result? More discoveries and a slew of uses for each gem found. IBM and Boehringer Ingelheim are turning the page in the antibody playbook, and it’s looking like a game-changer.
